This MSc will provide students with the skills and knowledge to allow them to participate effectively in the creation and growth of high-impact pharmaceutical business ventures. Its graduates will be ideally positioned to initiate their own start-up companies or join existing biotech or pharmaceutical businesses.
Students will learn how to develop and assess a new business concept, and how to raise finance for and market a business and its outputs. They will build their scientific skill set by exploring four scientific research areas in pharmaceutics, and will interact closely with and be mentored by those who have direct experience of initiating a start-up business.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits), a scientific research project (30 credits) and a business case development project (30 credits).
Optional modules Term One -Analysis and Quality Control -Preformulation -Formulation of Small Molecules -Personalised Medicine
Term Two -Pharmaceutical Biotechnology -Clinical Pharmaceutics -Nanomedicine -Formulation of Natural Products and Cosmeceuticals
Dissertation/report All students undertake two projects which comprise the major component of this MSc programme and culminate in two written reports and oral presentations. One of these is a short laboratory research project, while the second involves the development of a business case for a new pharmaceutical endeavour.
Teaching and learning The programme is delivered through a combination of lectures, tutorials, seminars and practical sessions as well as industrial visits. Assessment is through a combination of written examinations, coursework assignments and the project.
Graduates of this programme are expected to become involved in businesses in various areas of the pharmaceutical and biotechnology industries. They will be fully equipped with the skills to start their own businesses, and will be able to approach UCL Innovation and Enterprise to assist with this if desired. Alternatively, they may join small biotech or major pharmaceutical companies, pursue further research in academia, work in consulting, or join world-leading technology companies where there is increasing emphasis on healthcare and the life sciences.
The first cohort of students on the Pharmaceutical Formulation and Entrepreneurship MSc will graduate in 2016, therefore no information on graduate destinations is currently available.
Why study this degree at UCL?
This programme is unique in equipping students with a broad skill set in both medicine design and entrepreneurship. It is delivered by world-leading academics in both the UCL School of Pharmacy and UCL School of Management.
UCL staff with direct experience of launching a pharmaceutical start-up will teach students best practice and how to overcome the major challenges involved in enterprises of this kind.
UCL’s central London location combines state-of-the-art research with an entrepreneurial dynamic that fosters start-up creation, and provides access to venture capitalists, business angels, and world-leading pharmaceutical companies. UCL Innovation and Enterprise, UCL’s centre for entrepreneurship and business interaction, offers UCL students direct practical support in launching a business